Related Experiment Videos
Viral-mediated gene transfer in the cochlea
M A Weiss1, J C Frisancho, B J Roessler
1Kresge Hearing Research Institute, Department of Otolaryngology, University of Michigan Medical School, Ann Arbor 48109-0648, USA.
Summary
Gene transfer successfully introduced genetic material into cochlear cells in animal models. This research shows sustained transgene expression, offering potential for understanding and treating hearing loss.
Area of Science:
- Otolaryngology
- Molecular Biology
- Genetics
Background:
- Gene transfer is a novel therapeutic and investigative tool.
- Its application in the auditory system is a recent development.
- Understanding cochlear cell biology is crucial for treating hearing loss.
Purpose of the Study:
- To evaluate the efficacy of adenoviral gene transfer in the cochlea.
- To assess transgene expression and cytotoxicity in vivo and ex vivo.
- To explore the potential of gene transfer for understanding and treating hearing loss.
Main Methods:
- Utilized a replication-deficient adenoviral vector (Ad. RSVntlacZ).
- Conducted in vivo experiments targeting cochlear cells in adult animals.
- Performed ex vivo experiments transducing fibroblasts in vitro and inoculating them into the perilymph.
Main Results:
- Demonstrated successful gene transfer into multiple cochlear cell types in vivo.
- Observed efficient transduction and sustained transgene expression for several weeks.
- Found no major lethal cytotoxicity in spiral ganglion and epithelial cells.
- Confirmed adherence and transgene expression of transplanted fibroblasts in the perilymphatic space ex vivo.
Conclusions:
- Adenoviral gene transfer is effective in the cochlea, with sustained expression and minimal cytotoxicity.
- Transplanted fibroblasts can survive and express transgenes within the cochlear environment.
- Gene transfer holds promise for investigating the genetic basis of hearing loss and developing gene therapies.